Wolverine Asset Management’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Wolverine Asset Management’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-12,300	Closed	-$257K	–	1452
2016 Q3	$257K	Buy	+12,300	New	+$142K	﹤0.01%	833

Wolverine Asset Management's VTAE Position: Q4 2016 in Review

Wolverine Asset Management sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 12,300 shares — an estimated $257K sold.

Wolverine Asset Management first reported a position in VTAE in Q3 2016 and held it in 1 quarter. The position peaked at $257K in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

Wolverine Asset Management reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Wolverine Asset Management sold 12,300 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $257K.
Wolverine Asset Management first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2016 and held it in 1 quarter.
Wolverine Asset Management's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $257K in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Wolverine Asset Management's 13F filing for Q4 2016, filed 13 Feb 2017.